__________________ Effective Management of Acute and Chronic Pain with Opioid Analgesics, 2nd Edition
a. the scope of the controlled substance abuse problem in Utah and the nation; b. all elements of the FDA Blueprint for Prescriber Education under the FDA’s Extended-Release and Long-Acting Opioid Analgesics Risk Evaluation and Mitigation Strategy, as published July 9, 2012, or as it may be subsequently revised; c. the national and Utah-specific resources available to prescribers to assist in appropriate controlled substance and opioid prescribing; d. patient record documentation for controlled substance and opioid prescribing; e. office policies, procedures, and implementation; and f. some training regarding medical cannabis, as that term is defined in Section 26B-4-201. 7. a. The division, in consultation with the Utah Medical Association Foundation, shall determine whether a particular controlled substance prescribing class satisfies the educational content requirements of Subsections (4) and (6) for an M.D. or D.O. b. The division, in consultation with the applicable professional licensing boards, shall determine whether a particular controlled substance prescribing class satisfies the educational content requirements of Subsections (4) and (6) for a controlled substance prescriber other than an M.D. or D.O. c. The division may by rule establish a committee that may audit compliance with the Utah Risk Evaluation and Mitigation Strategy (REMS) Educational Programming Project grant, that satisfies the educational content requirements of Subsections (4) and (6) for a controlled substance prescriber. d. The division shall consult with the Department of Health and Human Services regarding the medical cannabis training described in Subsection (6)(f). 8. A controlled substance prescribing class required under this section: a. may be held: i. in conjunction with other continuing professional education programs; and ii. online; and b. does not increase the total number of state- required continuing professional education hours required for prescriber licensing.
9. The division may establish rules, in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, to implement this section. 10. A controlled substance prescriber who, on or after July 1, 2017, obtains a waiver to treat opioid dependency with narcotic medications, in accordance with the Drug Addiction Treatment Act of 2000, 21 U.S.C. Sec. 823 et seq., may use the waiver to satisfy the 3.5 hours of the continuing education requirement under Subsection (3) for two consecutive licensing periods.
UTAH SPECIAL DESIGNATION MATERIALS
1. SCOPE OF THE CONTROLLED SUBSTANCE ABUSE PROBLEM IN UTAH AND THE NATION Drug poisoning deaths are the leading cause of injury in Utah, outpacing firearms, falls, and motor vehicle crashes [1]. Every week, 10 Utah adults die from drug overdose, eight of which are from opioids, of which four are due specifically to prescription opioids [1]. (Opioid-related deaths include prescription opioids, synthetic opioids other than methadone [principally illicit fentanyl], and heroin) [2]. In the year 2020, it was determined that 82.2% of drug poisoning deaths were unintentional, compared to 14.1% self-inflicted, and 5.5% undetermined [1]. As mentioned above, prescription opioids accounted for 41% of the state’s unintentional and undetermined deaths due to drug poisoning between the years of 2000-2020 [1]. The number of prescriptions for opioid medications increased 5-fold in Utah between the years of 1997-2002, leading to establishment of programs to reduce harm and death by the Utah Department of Health. In 2009, The Utah Clinical Guidelines on Prescribing Opioids for Treatment of Pain was published and provides comprehensive recommendations for safe prescribing and use of opioid medications [2]. 2. NATIONAL AND UTAH SPECIFIC RESOURCES AVAILABLE TO PRESCRIBERS TO ASSIST IN APPROPRIATE CONTROLLED SUBSTANCE AND OPIOID PRESCRIBING NATIONAL RESOURCES: 1. The clinical assessment and decision-making tools found in the guidelines can be downloaded and printed here: http://www.health.utah.gov/prescription/guidelines. html 2. Centers for Disease Control and Prevention (CDC) has provided a checklist for prescribing opioids for chronic pain: http://stacks.cdc.gov/view/cdc/38025
37
MDUT1125
Powered by FlippingBook